Megola, Inc. (OTCPK:MGON) entered into definitive agreement to acquire License of Intellectual Property, Product Lines, Manufacturing & Other Assets of Medesol Global Inc. for $0.25 million on September 20, 2022. Medesol Global Inc receives 25,000 Restricted PFD D shares with a stated value of $10 per share. Megola's BOD will also determine future royalties to Medesol Global per specific product sales generated.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 USD | -0.99% | -7.41% | +316.67% |
1st Jan change | Capi. | |
---|---|---|
+316.67% | 2.95M | |
-21.07% | 38.78B | |
+8.22% | 24.74B | |
-4.72% | 16.66B | |
-20.40% | 6.91B | |
+1.19% | 5.62B | |
+5.12% | 3.32B | |
-1.60% | 2.28B | |
+2.60% | 2.21B | |
+20.22% | 938M |
- Stock Market
- Equities
- MGON Stock
- News Megola, Inc.
- Megola, Inc. entered into definitive agreement to acquire License of Intellectual Property, Product Lines, Manufacturing & Other Assets of Medesol Global Inc. for $0.25 million.